Literature DB >> 9350555

The optimization of the BANA test as a screening instrument for gingivitis among subjects seeking dental treatment.

W J Loesche1, C E Kazor, G W Taylor.   

Abstract

Porphyromonas gingivalis, Treponema denticola and Bacteroides forsythus have been implicated in periodontal disease and each possesses an enzyme capable of hydrolyzing the synthetic trypsin substrate, BANA. We have used a chairside test for BANA hydrolysis to diagnose an anaerobic periodontal infection in patients with advanced forms of clinical disease using a 15-min/55 degrees C incubation protocol. However, the BANA test performance is dependent upon the length and temperature of incubation. In the present study, we have evaluated a 5-min/35 degrees C, a 5-min/55 degrees C and a 15-min/55 degrees C incubation protocol to determine whether the performance of the BANA test could be optimized using plaque samples obtained from subjects seeking dental treatment. Logistic regression models were tested with age, smoking status, and gingivitis scores as covariates. The best fitting model obtained with the 5-min/35 degrees C protocol had a sensitivity of 71%, a specificity of 68%, a false-positive proportion of 9%, a false-negative proportion of 65%, and an overall accuracy of 80%. When maximum likelihood estimates were obtained in this model, plaques from individuals who reported that they currently smoked were 9.57x, and those who quit smoking were 4.73x more likely to have a positive BANA score than someone who never smoked. Plaques were 4.55x more likely to be BANA-positive if they were removed from sites with gingivitis. These findings indicate that the performance of the BANA test is best using the 5-min/35 degrees C incubation protocol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9350555     DOI: 10.1111/j.1600-051x.1997.tb00188.x

Source DB:  PubMed          Journal:  J Clin Periodontol        ISSN: 0303-6979            Impact factor:   8.728


  8 in total

1.  Anaerobic Periodontal Infections as Risk Factors for Medical Diseases.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-04       Impact factor: 3.725

Review 2.  Diagnostic biomarkers for oral and periodontal diseases.

Authors:  Mario Taba; Janet Kinney; Amy S Kim; William V Giannobile
Journal:  Dent Clin North Am       Date:  2005-07

Review 3.  Oral fluid-based biomarkers of alveolar bone loss in periodontitis.

Authors:  Janet S Kinney; Christoph A Ramseier; William V Giannobile
Journal:  Ann N Y Acad Sci       Date:  2007-03       Impact factor: 5.691

4.  Saliva/pathogen biomarker signatures and periodontal disease progression.

Authors:  J S Kinney; T Morelli; T Braun; C A Ramseier; A E Herr; J V Sugai; C E Shelburne; L A Rayburn; A K Singh; W V Giannobile
Journal:  J Dent Res       Date:  2011-03-15       Impact factor: 6.116

Review 5.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

6.  Fast, Simple, and Highly Specific Molecular Detection of Porphyromonas gingivalis Using Isothermal Amplification and Lateral Flow Strip Methods.

Authors:  Duobao Ge; Fang Wang; Yanyan Hu; Bendi Wang; Xuzhu Gao; Zhenxing Chen
Journal:  Front Cell Infect Microbiol       Date:  2022-05-25       Impact factor: 6.073

7.  Periodontal status of adult patients treated with fixed buccal appliances and removable aligners over one year of active orthodontic therapy.

Authors:  Marzieh Karkhanechi; Denise Chow; Jennifer Sipkin; David Sherman; Robert J Boylan; Robert G Norman; Ronald G Craig; George J Cisneros
Journal:  Angle Orthod       Date:  2012-06-22       Impact factor: 2.079

Review 8.  Periodontal proteomics: wonders never cease!

Authors:  Harpreet Singh Grover; Shalini Kapoor; Neha Saksena
Journal:  Int J Proteomics       Date:  2013-12-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.